Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model

Arrington, 1996, Complications of iliac crest bone graft harvesting, Clin. Orthop. Relat. Res., 329, 300, 10.1097/00003086-199608000-00037 Aspenberg, 2010, Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures, J. Bone Miner. Res., 25, 404, 10.1359/jbmr.090731 Baron, 2013, WNT signaling in bone homeostasis and disease: from human mutations to treatments, Nat. Med., 19, 179, 10.1038/nm.3074 Boden, 2000, The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report, Spine (Phila Pa 1976), 25, 376, 10.1097/00007632-200002010-00020 Boden, 2002, Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: Volvo award in clinical studies, Spine (Phila Pa 1976), 27, 2662, 10.1097/00007632-200212010-00005 Canalis, 2010, Update in new anabolic therapies for osteoporosis, J. Clin. Endocrinol. Metab., 95, 1496, 10.1210/jc.2009-2677 Canalis, 2007, Mechanisms of anabolic therapies for osteoporosis, N. Engl. J. Med., 357, 905, 10.1056/NEJMra067395 Dempster, 1993, Anabolic actions of parathyroid hormone on bone, Endocr. Rev., 14, 690 Fermor, 1995, PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats, J. Bone Miner. Res., 10, 1935, 10.1002/jbmr.5650101213 Gallacher, 2010, Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review, Calcif. Tissue Int., 87, 469, 10.1007/s00223-010-9420-x Jilka, 2007, Molecular and cellular mechanisms of the anabolic effect of intermittent PTH, Bone, 40, 1434, 10.1016/j.bone.2007.03.017 Kaito, 2005, Biomaterials, 26, 73, 10.1016/j.biomaterials.2004.02.010 Kaito, 2013, Synergistic effect of bone morphogenetic protein-2 and 7 by ex vivo gene therapy in a rat spinal fusion model, J. Bone Joint Surg. Am., 95, 1612, 10.2106/JBJS.L.01396 Kamiya, 2008, BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway, Development, 135, 3801, 10.1242/dev.025825 Komatsubara, 2005, Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora, Bone, 36, 678, 10.1016/j.bone.2005.02.002 Leahy, 2010, Correlation of mechanical properties within the equine third metacarpal with trabecular bending and multi-density micro-computed tomography data, Bone, 46, 1108, 10.1016/j.bone.2010.01.366 Manabe, 2007, Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys, Bone, 40, 1475, 10.1016/j.bone.2007.01.015 Maycas, 2015, Role of the parathyroid hormone type 1 receptor (PTH1R) as a mechanosensor in osteocyte survival, J. Bone Miner. Res., 30, 1231, 10.1002/jbmr.2439 Morimoto, 2014, Effect of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone formation in a rat model of spinal fusion, J. Bone Joint Surg. Am., 96, 10.2106/JBJS.M.01097 Nakashima, 2011, Evidence for osteocyte regulation of bone homeostasis through RANKL expression, Nat. Med., 17, 1231, 10.1038/nm.2452 Neer, 2001, Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N. Engl. J. Med., 344, 1434, 10.1056/NEJM200105103441904 Pacheco-Costa, 2015, Defective cancellous bone structure and abnormal response to PTH in cortical bone of mice lacking Cx43 cytoplasmic C-terminus domain, Bone, 81, 632, 10.1016/j.bone.2015.09.011 Rhee, 2011, PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling, J. Bone Miner. Res., 5, 1035, 10.1002/jbmr.304 Robertson, 2001, Natural history of posterior iliac crest bone graft donation for spinal surgery: a prospective analysis of morbidity, Spine (Phila Pa 1976), 26, 1473, 10.1097/00007632-200107010-00018 Saini, 2013, Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH, J. Biol. Chem., 288, 20122, 10.1074/jbc.M112.441360 Shields, 2006, Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion, Spine (Phila Pa 1976), 31, 542, 10.1097/01.brs.0000201424.27509.72 Smucker, 2006, Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine, Spine (Phila Pa 1976), 31, 2813, 10.1097/01.brs.0000245863.52371.c2 Steinmann, 1992, Pseudarthrosis of the spine, Clin. Orthop. Relat. Res., 284, 80, 10.1097/00003086-199211000-00011 Takada, 2009, Wnt and PPAR gamma signaling in osteoblastogenesis and adipogenesis, Nat. Rev. Rheumatol., 5, 442, 10.1038/nrrheum.2009.137 Tam, 1982, Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration, Endocrinology, 110, 506, 10.1210/endo-110-2-506 Urist, 1965, Bone formation by autoinduction, Science, 150, 893, 10.1126/science.150.3698.893 Wang, 2003, Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats, J. Bone Joint Surg. Am., 85, 905, 10.2106/00004623-200305000-00020 Wozney, 1988, Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528, 10.1126/science.3201241 Yu, 2012, Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling, J. Bone Miner. Res., 27, 2001, 10.1002/jbmr.1663 Zhang, 2009, Mechanical stimulus alters conformation of type 1 parathyroid hormone receptor in bone cells, Am. J. Phys. Cell Physiol., 296, C1391, 10.1152/ajpcell.00549.2008